[1] Hofmann MA,Amiral J,Kohl B,et al. Hyperhomocysteinemia and endothelia dysfuntion in IDDM [J]. Diabetes Care,1997,20:1880-5. [2] Wall RT,Harlan JM,Harker LA,et al. Homocysteine-induced endothelial cell injury in vitro:a model for the study of vascular injury[J]. Thromb Res,1980,18:113-5. [3] Malinow MR Plasma homocysteine:A risk factor for arterial occlusive disease[J]. J Nutr,1996,126:1238-43. [4] Moghadasiam MH,Mcmanus BM,Frohlich JJ. Homocysteine and coronary artery disease [J]. Arch Intern Med,1997,157(10):2299-304. [5] Passaro A,Delia K,Pareschi PL,et al. Factors influencing plasma homocysteine levels in type 2 diabetes [J]. Diabetes Care,2000,3:420-4. [6] 刘海波,高润霖,惠汝太,等.血浆同型半胱氨酸与冠状动脉病变支数的关系[J].中华内科杂志,1999,38(12):821-3.Liu HB,Gao RL,Hui RT,et al.The association between plasma home cysteine andthe number of coronary artery with stenosis[J].Chin JIntern Med,1999,38(12):821-3. [7] 杨国庆,陆菊明,潘长玉.血浆同型半胱氨酸浓度与2型糖尿病视网膜病变的关系[J].中华内科杂志,2002,41(1):34-8.Yang GQ,Lu JM,Pan CY.Theimpact of plasma homocysteinelevel on development of at in type 2 diabetes mellitus[J].Chin J Intern Med,2002,41(1):34-8. [8] 李兴,朱亦,赵宝珍.糖尿病血清同型半胱氨酸测定的临床意义[J].中华内分泌代谢杂志(Chin J Endocrinol Metab),2001,17(3),169-70. [9] 梁伟,赵列宾,王巍,等.2型糖尿病合并冠心病患者血清同型半胱氨酸水平的研究[J].中华内分泌代谢杂志(Chin J Endocrinol Metab),2002,18(4):311-2. |